Clinical Trials Directory

Trials / Completed

CompletedNCT01549275

Primary Cell Culture of Hepatic Tumorous Cells From Routine Fine-needle Aspiration

Kaohsiung Medical University Hospital

Status
Completed
Phase
Study type
Observational
Enrollment
105 (actual)
Sponsor
Kaohsiung Medical University Chung-Ho Memorial Hospital · Academic / Other
Sex
All
Age
20 Years – 90 Years
Healthy volunteers
Not accepted

Summary

The purposes of this prospective study were to evaluate the successful rate of primary culture of hepatocellular carcinoma cells and cancer-associated fibroblasts from the residual specimens in routine fine-needle aspiration of hepatic tumor and the potential application of this method as an additional tool for personalized treatment of hepatocellular carcinoma patients.

Detailed description

Fine-needle aspiration (FNA) cytology or biopsy of hepatic tumor is frequently applied in the collection of specimens because it is considered safe, efficacious, accurate and cost effective. Our previous study from small number of patients showed that specimens obtained from FNA had potential to be applied for primary culture of cancer cells. This study was to modified our method for primary culture of both hepatocellular carcinoma cells and cancer-associated fibroblasts in patients with tumor measuring larger than or equal to 3cm. All patients received one session of aspiration for the diagnosis of hepatic tumor. The aspirated specimens were applied for both cytologic and pathologic examinations at first. After then, 10 mL 0.9% NaCl was aspirated by the same needle connected with the same syringe and injected into 15 mL sterilized centrifugation tube. If the tube contained visible specimens, these specimens were sent for primary culture.

Conditions

Timeline

Start date
2010-04-01
Primary completion
2013-01-01
Completion
2013-07-01
First posted
2012-03-09
Last updated
2015-10-08
Results posted
2015-10-08

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT01549275. Inclusion in this directory is not an endorsement.